Noevir Holdings Co (TSE:4928) ROCE % : 22.27% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Noevir Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Noevir Holdings Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 22.27%.

Noevir Holdings Co ROCE % Historical Data

The historical data trend for Noevir Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noevir Holdings Co ROCE % Chart

Noevir Holdings Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROCE %

Get a 7-Day Free Trial

16.36

11.03

11.87

14.56

16.47

Noevir Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															20.80	15.66	19.09	13.72	22.27

Noevir Holdings Co ROCE % Calculation

Noevir Holdings Co's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	11027	/	( ( (76781 - 9653)	+	(77246 - 10506) )	/ 2 )
	=	11027	/	( (67128	+	66740)	/ 2 )
	=	11027	/	66934
	=	16.47 %

Noevir Holdings Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	14140	/	( ( (77246 - 10506)	+	(71745 - 11505) )	/ 2 )
	=	14140	/	( ( 66740	+	60240 )	/ 2 )
	=	14140	/	63490
	=	22.27 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Noevir Holdings Co (TSE:4928) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Noevir Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Noevir Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Noevir Holdings Co (TSE:4928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Noevir Holdings Co Ltd (TSE:4928) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6-13-1 Minatojimanakamachi, Chuo-ku, Kobe, JPN, 650-8521

Website

http://www.noevirholdings.co.jp

Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.

Noevir Holdings Co (TSE:4928) Headlines

No Headlines